In-stent Restenosis and Pericoronary Fat Attenuation Index
- Conditions
- In-stent Restenosis
- Registration Number
- NCT05512832
- Lead Sponsor
- RenJi Hospital
- Brief Summary
This study aims to investigate the predictive value of fat attenuation index (FAI) and related radiomics characteristics of pericoronary fat in patients after percutaneous coronary intervention (PCI) for the occurrence of in-stent restenosis (ISR) during the follow-up period (9 to 24 months). The results of this study are expected to provide an early assessment of the inflammation around the coronary lesion segment in patients after PCI, and provide a basis for early targeted intensive drug therapy in clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 126
- Patients with coronary heart disease who have undergone PCI;
- Patients followed up coronary angiography 9 to 24 months after PCI;
- Patients received chest CT examination during inpatient/outpatient follow-up;
- Patients with diseases of the immune system;
- Patients with history of tumor diseases;
- Patients with chronic/acute infectious diseases;
- Image quality is not sufficient for analysis;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fat attenuation index (FAI) 2022.8.15-2023.8.14 The pericoronary FAI was defined as the mean CT attenuation of the pericoronary adipose tissue (-190 to -30 HU). Peri-stent FAI was measured around the stent segment of all 3 major epicardial coronary vessels.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
🇨🇳Shanghai, Shanghai, China